Search Tag: prostate cancer

Cardiology Management

#ESCCongress: PRONOUNCE Trial - Safety of ADT Remains Unresolved

2021 30 Aug

Late-breaking research from the PRONOUNCE trial was presented in a Hot Line session at ESC Congress 2021. The cardiovascular safety of androgen deprivation therapy (ADT) for prostate cancer remains unresolved after the trial was terminated early.   Every year, approximately one million men are diagnosed with prostate cancer worldwide. These patients... Read more

Health Management

Biparametric MRI: A New Standard for Prostate Cancer Imaging?

2021 12 Jul

A lone and discordant voice supported by few at first, biparametric prostate magnetic resonance imaging has been gradually gaining attention and visibility as a reliable, faster, and cheaper alternative to conventional multiparametric magnetic resonance imaging and could become a new standard of care in the near future. Key Points The role... Read more

IMAGING Management

Diagnosing Prostate Cancer Using Artificial Intelligence

2021 25 Jan

Prostate cancer is one of the most common cancers among men. Patients are determined to have prostate cancer based on Prostate-Specific Antigen (PSA), a prostate-specific antigen used as an index for the screening of prostate cancer. However, diagnostic accuracy for prostate cancer is as low as 30%. That is why a large number of patients have to undergo... Read more

Executive Health Management

Cancer Care: What to Expect, What to Do

2020 21 Apr

A research predicts a decline in cancer mortality rates in 2020 in the EU. However, due to the COVID-19 pandemic cancer patient safety is compromised, but can still be improved with certain policies.   You may also like : Prostate is Now Most Common Cancer   Cancer in the EU Total cancer mortality rates in the... Read more

Executive Health Management

Prostate is Now Most Common Cancer

2020 29 Jan

Prostate cancer is now the most commonly diagnosed cancer in England. According to the data revealed by Public Health England (PHE), in 2018 (latest data available), it overtook breast cancer for the first time. You may also like: RSNA 2019: Novel MRI-Guided Ultrasound Treatment Destroys Prostate Cancer This is attributed... Read more

IMAGING Management

RSNA 2019: Novel MRI-Guided Ultrasound Treatment Destroys Prostate Cancer

2019 02 Dec

  Good news for men with prostate problems including prostate cancer and benign prostate enlargement.      A new minimally invasive method, the MRI-guided transurethral ultrasound ablation (TULSA), has been shown to be effective in treating prostate cancer with minimal side effects, according to a new study presented at the annual meeting... Read more

Executive Health Management

EFU 2019 - 4th Emirates Forum of Urology 2019

2019 12 Apr

Find Emirates Forum of Urology on Social Media Read more

IMAGING Management

2nd Annual BIR Theranostics update 2019

2019 08 Feb

Find BIR on Social Media: Read more

IMAGING Management

RSNA 2019: PSMA-based PET Radiotracers Transforming Care in Prostate Cancer

2018 04 Jul

A large number of radiotracers are currently being evaluated for prostate-specific membrane antigen (PSMA) PET, which is becoming a central tool in the staging of prostate cancer, according to a review published in the American Journal of Roentgenology. Staging in various clinical contexts of prostate cancer, such as the preoperative setting... Read more

IMAGING Management

Biparametric MRI improves prostate cancer detection

2018 12 Jun

In a single-centre cohort study of 1,020 men who underwent both biparametric targeted and standard transrectal ultrasound-guided biopsies, low-suspicion biparametric magnetic resonance imaging (bpMRI) had a high negative predictive value (97%) in ruling out significant prostate cancer on confirmatory biopsies. The findings are published online... Read more